Private Equity

Exclusive I Goldman Sachs Private Equity In Talks To Buy Minority Stake In Ipo-bound Biocon Biologics

by moneycontrol.com posted 6months ago 168 views
If the deal — which may value the firm in excess of $3.5 billion — fructifies, it would mark the third successive investment in 2020 for Kiran Mazumdar Shaw-led Biocon Biologics.

In this article